Skip to main content
OpenTrials
Completed

NCT Number: NCT03807648

I USE LR in the ED

To study the difference in mortality and major adverse kidney events during and after treatment in the emergency department with intravenous fluids per standard of care at 30 days before and after the system-wide implementation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Kidney Injury

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Intermountain Medical Center

Murray, Utah, 84157-7000, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients (≥18 years) receiving a minimum of 1000ml of intravenous fluids starting in the emergency department per standard of care

Exclusion criteria

  • Patients aged ≤17 years
  • Previously enrolled patients with >1 ED admission within the 30-day follow-up period

Treatment and study plan

Data Inclusion

Other

Patients in this group will be included in the project

Primary outcomes

  1. Number of participants with major Adverse Kidney Events

    Time frame: within 30 days or at hospital discharge

    death from any cause, new renal replacement therapy or persistent renal dysfunction

  2. LR IV Fluids administered

    Time frame: Through study completion (an average of 1 year)

    Proportion of LR IV fluids following implementation

Secondary outcomes

  1. Rate of hospital admission and readmission

    Time frame: Within 30 days of initial ED encounter

  2. Cost

    Time frame: Through study completion (an average of 1 year)

    Direct costs of ED care and hospitalization

Sponsors and collaborators

Lead sponsor

Intermountain Health Care, Inc.

Other

Registry information

Official study title

Intermountain Utah Study Evaluating the Implementation of Lactated Ringers as Standard Resuscitation Fluid Starting in Emergency Department

Important dates

Study start
2018
Primary completion
2019
Study completion
2020
First posted
Jan 17, 2019
Registry last updated
Feb 12, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.